The ANCA / PANCA Test detects antibodies associated with autoimmune diseases, helping in diagnosis and monitoring.

No specific preparation is usually required, but inform your healthcare provider about any medications you are taking.

Results are typically available within a few days, allowing for prompt medical decision-making and disease management.

Elevated levels suggest the presence of an autoimmune disease, such as vasculitis or granulomatosis with polyangiitis.

Yes, the test can help differentiate between types of autoimmune diseases based on the pattern and concentration of antibodies.

CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.

The duration of the surgery varies depending on the complexity of the procedure and the extent of the cancer, typically ranging from 2 to 6 hours.